Use and Outcomes of Induction Therapy in Well-Matched Kidney Transplant Recipients.
Rhys D R EvansJames H LanMatthew J KadatzSandeep BrarDoris T ChangLachlan C McMichaelJagbir GillJohn S GillPublished in: Clinical journal of the American Society of Nephrology : CJASN (2022)
Use of induction therapy with T cell-depleting therapy or IL-2 receptor antagonists in first kidney transplant recipients who are well matched with their donor at the HLA-A, -B, -DR, -DQB1 gene loci is not associated with improved post-transplant outcomes.